Drugs regulator moves import approvals fully online with new rulebook
Revised CDSCO guidance mandates online applications, stricter registration norms for overseas manufacturers and digital compliance through the SUGAM portal.
India’s central drugs authority is set to revolutionize the approval process for bulk drugs and finished medicines by transitioning to an entirely online system, according to documents reviewed by Mint. The new rulebook, currently under development, aims to streamline and digitize the current cumbersome import procedures, according to experts familiar with the matter. The initiative is part of a broader push to modernize India’s pharmaceutical sector and improve efficiency in healthcare delivery.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
